Literature DB >> 2581698

Induction of natural killer cell activity of thoracic duct lymphocytes by polyinosinic-polycytidylic acid (poly(I:C)) or interferon.

K L Fresa, R Korngold, D M Murasko.   

Abstract

Natural killer (NK) cell activity of thoracic duct lymphocytes (TDL) was examined in normal mice and in mice treated with polyinosinic-polycytidylic acid (poly(I:C) and interferon (IFN). TDL from mice treated with phosphate-buffered saline (PBS) expressed little or no NK cell activity against YAC-1 target cells at effector-to-target ratios of up to 200:1, even after in vitro treatment with murine L-cell IFN. In contrast, TDL from poly(I:C)- or IFN-treated mice expressed significant NK activity, which correlated with the significantly higher NK activity of splenocytes from these mice compared to the NK activity of splenocytes from PBS-treated mice. These data indicate that although TDL from normal mice express no detectable NK cell activity, NK cell activity can be induced in TDL by in vivo treatment with poly(I:C) or IFN.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2581698     DOI: 10.1016/0008-8749(85)90231-x

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  4 in total

1.  The rat diabetes susceptibility locus Iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection.

Authors:  Elizabeth P Blankenhorn; Lucy Rodemich; Cristina Martin-Fernandez; Jean Leif; Dale L Greiner; John P Mordes
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

Review 2.  NK cells in the tumor microenvironment.

Authors:  Stine K Larsen; Yanhua Gao; Per H Basse
Journal:  Crit Rev Oncog       Date:  2014

3.  Polyinosinic:polycytidylic acid is a potent activator of endothelial cells.

Authors:  J Doukas; A H Cutler; J P Mordes
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

Review 4.  Biology of natural killer cells.

Authors:  G Trinchieri
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.